AI brief of an SEC Form 8-K · Cigna (CI)

Cigna names Brian Evanko president and COO, Ann Dennison CFO; reaffirms 2025 outlook

Neutral Impact 4 of 5 leadership Written later

Cigna Group announced leadership changes effective March 31, 2025: Brian C. Evanko becomes President and Chief Operating Officer, and Ann M. Dennison becomes Executive Vice President and Chief Financial Officer. The company also reaffirmed its 2025 adjusted income from operations outlook of at least $29.50 per share, which matters to shareholders because it signals no change to prior guidance alongside a senior management reshuffle.

Key points

  • Evanko's effective base salary is $1,100,000, with a 2025 EIP annual target of $2,200,000 and a 2026 LTI target of $6,700,000.
  • Dennison's effective base salary is $800,000, with a 2025 EIP annual target of $1,100,000 and a 2026 LTI target of $3,500,000, plus a 2025-2027 transitional strategic performance share grant valued at $750,000.
  • Eric P. Palmer's employment as EVP for Enterprise Strategy and CEO of Evernorth Health Services ends April 26, 2025; separation terms will be reported separately.
  • Cigna reaffirmed 2025 adjusted income from operations of at least $29.50 per share, Evernorth pre-tax adjusted income of at least $7.2 billion, and Cigna Healthcare pre-tax adjusted income of at least $4.1 billion.

The filing

CompanyCigna (CI)
Form8-K, current report
Filed with the SECMar 13, 2025, 7:42 AM ET
Accession number0001140361-25-008555

Items reported: 5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:21 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on March 13, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.